In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
1 week 12 hours ago
1 week 1 day ago
13 weeks 3 days ago
19 weeks 1 day ago
30 weeks 1 day ago
31 weeks 20 hours ago
32 weeks 4 days ago
33 weeks 1 day ago
33 weeks 3 days ago
37 weeks 6 days ago